Article
Exogenous BMP9 therapy ameliorates primary graft dysfunction post lung transplantation
2025-10-01
Abstract excerpt
<h4>ABSTRACT</h4> Primary graft dysfunction (PGD) is a leading cause of early mortality after lung transplantation and is driven by ischemia-reperfusion injury (IRI), which destabilizes the pulmonary endothelium. Bone morphogenetic protein 9 (BMP9), a vascular quiescence factor of the TGF superfamily, maintains endothelial homeostasis through ALK-1/BMPR2-mediated signaling. Herein, this work identified a previous...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d948ab06-29a8-52aa-bec1-2ab1139c68ec
- DOI
- 10.1101/2025.09.30.679530
